64D-3.029. Diseases or Conditions to be Reported  


Effective on Thursday, October 20, 2016
  • 1(1) Diseases or conditions listed in subsection (3), below, are identified by the Department as being of public health significance. These diseases or conditions must be reported by the practitioner, hospital, laboratory, or other individuals via telephone (with subsequent written report within 72 hours, see Rules 64D-3.030-.033, F.A.C.), facsimile, electronic data transfer, or other confidential means to the Department, which includes the County Health Departments. Reporters are not prohibited from reporting diseases or conditions not listed by rule. 79Reports should include all associated testing results performed (e.g. serogroup, serotype, and antimicrobial susceptibility results). 94Physicians and other healthcare providers using point of care tests for diagnosis of infectious diseases must report test results to the Department when they are indicative of an infectious disease reportable directly to the Department by laboratories unless such point of care testing is subject to routine reflex testing by a supplementary or confirmatory testing the results of which would be reportable.

    156(2) Definitions to be used with subsection (3), below:

    165(a) 166“Reportable Diseases or Conditions” 170– The definitions of “suspected case” and “confirmed case” for reportable diseases or conditions are set forth in “Surveillance Case Definitions for Select Reportable Diseases in Florida,” January 2016 version 1.1, incorporated by reference, available online at: 208https://www.flrules.org/Gateway/reference.asp?No=Ref-07442210.

    211(b) 212“Suspect Immediately” 214– A reportable condition of urgent public health importance. Report without delay upon the occurrence of any of the following: initial suspicion, receipt of a specimen with an accompanying request for an indicative or confirmatory test, findings indicative thereof, or suspected diagnosis. Reports that cannot timely be made during the County Health Department business day shall be made to the County Health Department after-hours duty official. If unable to do so, the reporter shall contact the Department after-hours duty official at (850)245-4401.

    296(c) 297“Immediately” 298– A reportable condition of urgent public health importance. Report without delay upon the occurrence of any of the following: an indicative or confirmatory test, findings indicative thereof, or diagnosis. Reports that cannot timely be made during the County Health Department business day shall be made to the County Health Department after-hours duty official. If unable to do so, the reporter shall contact the Department after-hours duty official at (850)245-4401.

    368(d) 369“Next Business Day” 372– Report before the closure of the County Health Department’s next business day following suspicion or diagnosis.

    389(e) 390“Other” 391– Report consistent with the instruction in and footnotes to subsection (3), below.

    404(3) “406Table of Reportable Diseases or Conditions to Be Reported”

    415Practitioner Reporting

    417Laboratory Reporting

    419Reportable Diseases or Conditions

    423Timeframes

    424Evidence of current or recent infection with etiological agents and all associated testing results performed should be reported (e.g. species, serogroup, serotype, and antimicrobial susceptibility *2 results)

    451Timeframes

    452Suspect Immediately

    454Immediately

    455Next Business Day

    458Other

    459Submit isolates or specimens for confirmation *1

    466Suspect Immediately

    468Immediately

    469Next Business Day

    472Other

    473Any case, cluster of cases, outbreak, or exposure to an infectious or non-infectious disease, 487condition, or agent 490found in the general community or any defined setting such as a hospital, school or other institution, not listed in this rule that is of urgent public health significance. This includes human cases, clusters, or outbreaks spread person-to-person, by animals or vectors or from an environmental, food or waterborne source of exposure; those that result from a deliberate act of terrorism; and unexplained deaths possibly due to unidentified infectious or chemical causes.

    562X

    563X

     

     

    564Detection in one or more specimens of etiological agents of a disease or condition not listed in this Rule that is of urgent public health significance. This includes the identification of etiological agents that are suspected to be the cause of clusters, or outbreaks spread person-to-person, by animals or vectors or from an environmental, food, or waterborne source of exposure; those that result from a deliberate act of terrorism; and unexplained deaths due to unidentified infectious or chemical causes.

     

    643X

    644X

     

     

    645Acquired Immune

    647Deficiency Syndrome (AIDS)

     

     

     

    6502 weeks

    652Acquired Immune

    654Deficiency Syndrome (AIDS)

    657Laboratory Reporting Not Applicable

    661Amebic Encephalitis

     

    663X

     

     

    664Naegleria fowleri, Balamuthia mandrillaris, or Acanthamoeba 670species

     

     

    671X

     

     

    672Anthrax

    673X

    674X

     

     

    675Bacillus anthracis

    677X

    678X

    679X

     

     

    680Antimicrobial resistance surveillance

    683Practitioner Reporting Not Applicable

    687Antimicrobial resistance surveillance (for organisms not otherwise listed in this table), 698Acinetobacter baumannii, Citrobacter 701species, 702Enterococcus 703species, 704Enterobacter 705species, 706Escherichia coli 708species, 709Klebsiella 710species, 711Pseudomonas aeruginosa, 713Serratia 714species, isolated from a normally sterile site *3

     

     

     

    722X

     

    723Arsenic Poisoning *4a

     

     

    726X

     

    727Laboratory results as specified in the surveillance case definition *4a

     

     

     

    737X

     

    738Arboviral infections, not otherwise listed in this table (disease due to) *5

    750X

     

     

     

    751Including but not limited to: Flaviviridae, Togaviridae (e.g. chikungunya, Western equine encephalitis), Bunyaviridae (e.g. Heartland, Rift Valley Fever) *5

    770X

    771X

     

     

     

    772Babesiosis

     

     

    773X

     

    774Babesia spp.

    776X

     

     

    777X

     

    778Botulism, foodborne, other (includes wound and unspecified)

    785X

    786X

     

     

    787Clostridium botulinum 789or botulinum toxin

    792X

    793X

    794X

     

     

    795Botulism, infant

     

     

    797X

     

    798Clostridium botulinum 800or botulinum toxin

    803X

     

     

    804X

     

    805Brucellosis

    806X

    807X

     

     

    808Brucella 809species

    810X

    811X

    812X

     

     

    813California serogroup viruses 816(disease due to)

     

     

    819X

     

     

    820California serogroup viruses such 824as Jamestown Canyon, Keystone, and Lacrosse

    830X

     

     

    831X

     

    832Campylobacteriosis *4b

     

     

    834X

     

    835Campylobacter 836species *4b

     

     

     

    838X

     

    839Cancer (except non-melanoma skin cancer, and including benig847n and borderline intracranial and CNS tumors) 854*6

     

     

     

    8556 months

    857Pathological or tissue diagnosis of cancer (except non-melanoma skin cancer and including benign and borderline intracranial and CNS tumors)

     

     

     

     

    8766 months

    878Carbon monoxide poisoning

     

     

    881X

     

    882A volume fraction ≥ 0.09 (9%) of carboxyhemoglobin in blood

     

     

     

    892X

     

    893CD-4 absolute count and percentage of total lymphocytes

    901Practitioner Reporting Not Applicable

    905CD-4 absolute count and percentage of total lymphocytes *7

     

     

     

     

    9143 days

    916Chancroid

     

     

    917X

     

    918Haemophilus ducrey920i

     

     

     

    921X

     

    922Chlamydia *8

     

     

    924X

     

    925Chlamydia trachomatis

     

     

     

    927X

     

    928Cholera

    929X

    930X

     

     

    931Vibrio cholerae

    933X

    934X

    935X

     

     

    936Ciguatera fish poisoning

     

     

     

    939X

     

    940Ciguatera fish poisoning

    943Laboratory Reporting Not Applicable

    947Congenital anomalies *9

     

     

     

    9506 months

    952Congenital anomalies

    954Laboratory tests as specified in Rule 96064D-3.035, 961F.A.C.

    962Conjunctivitis in neonates < 14 days old

     

     

    965X

     

    966Conjunctivitis in neonates < 14 days old

    969Laboratory Reporting Not Applicable

    973Creutzfeld-Jakob disease (CJD) *10

     

     

    977X

     

    97814-3-3 or tau protein detection in CSF or immunohistochemical test or any brain pathology suggestive of CJD *10

     

     

     

    996X

     

    997Cryptosporidiosis *4b

     

     

    999X

     

    1000Cryptosporidium 1001species *4b

     

     

     

    1003X

     

    1004Cyclosporiasis

     

     

    1005X

     

    1006Cyclospora cayetanensis

    1008X

     

     

    1009X

     

    1010Dengue *5

    1012X

     

     

     

    1013Dengue virus *5

    1016X

    1017X

     

     

     

    1018Diphtheria

    1019X

    1020X

     

     

    1021Corynebacterium diphtheriae

    1023X

    1024X

    1025X

     

     

    1026Eastern equine encephalitis

     

     

    1029X

     

    1030Eastern equine encephalitis virus

    1034X

     

     

    1035X

     

    1036Ehrlichiosis/Anaplasmosis

     

     

    1037X

     

    1038Anaplasma 1039species or 1041Ehrlichia 1042species

    1043X

     

     

    1044X

     

    1045Escherichia coli 1047Shiga toxin-producing (disease due to) *4b

     

     

    1053X

     

    1054Escherichia coli 1056Shiga toxin-producing *4b

    1059X

     

     

    1060X

     

    1061Giardiasis (acute) *4b

     

     

    1064X

     

    1065Giardia 1066species *4b

     

     

     

    1068X

     

    1069Glanders

    1070X

    1071X

     

     

    1072Burkholderia mallei

    1074X

    1075X

    1076X

     

     

    1077Gonorrhea *8

     

     

    1079X

     

    1080Neisseria gonorrhoeae

     

     

     

    1082X

     

    1083Granuloma inguinale

     

     

    1085X

     

    1086Calymmatobacterium granulomatis

     

     

     

    1088X

     

    1089Haemophilus influenzae, 1091meningitis and invasive disease, in children < 5 years old

    1097X

    1098X

     

     

    1099Haemophilus influenzae, 1101all ages, isolated from a normally sterile site *11

    1110X

    1111X

    1112X

     

     

    1113Hansen disease (Leprosy)

     

     

    1116X

     

    1117Mycobacterium leprae

     

     

     

    1119X

     

    1120Hantavirus infection

     

    1122X

     

     

    1123Hantavirus

    1124X

     

    1125X

     

     

    1126Hemolytic uremic syndrome

     

    1129X

     

     

    1130Not Applicable

    1132Hepatitis A *4b, 12

     

    1136X

     

     

    1137Hepatitis A*4b, 12

     

     

    1140X

     

     

    1141Hepatitis B, C, D, E and G *12

     

     

    1149X

     

    1150Hepatitis B, C, D, E and G Virus *12

     

     

     

    1159X

     

    1160Hepatitis B surface antigen (HBsAg)-positive in a pregnant woman or a child up to 24 months old

     

     

    1177X

     

    1178Hepatitis B surface antigen (HBsAg)

     

     

     

    1183X

     

    1184Herpes B virus, possible exposure

     

    1189X

     

     

    1190Herpes B virus, possible exposure

    1195Laboratory Reporting Not Applicable

    1199Herpes simplex virus (HSV) in infants up to 60 days old with disseminated infection with involvement of liver, encephalitis and infections limited to skin, eyes and mouth *13

     

     

    1227X

     

    1228HSV 1 or HSV 2 by direct FA, PCR, DNA or Culture *13

     

     

     

    1241X

     

    1242HSV – anogenital in children < 12 years of age 1247*8, 13

     

     

    1249X

     

    1250HSV 1 or HSV 2 by direct FA, PCR, DNA or Culture *13

     

     

     

    1263X

     

    1264Human immunodeficiency virus (HIV) infection

     

     

     

    12692 weeks

    1271Repeatedly reactive enzyme immunoassay, followed by a positive confirmatory tests, (e.g. Western Blot, IFA): Positive result on any HIV virologic test (e.g. p24 AG, Nucleic Acid Test (NAT/NAAT) or viral culture). All viral load (detectable and undetectable) test results.*14, 15

     

     

     

     

    13113 days

     

    1313Human immunodeficiency virus (HIV) Exposed Newborn – infant < 18 months of age born to a HIV infected woman

     

     

    1321X

     

    1322All HIV test results (e.g., positive or negative immunoassay, positive or negative virologic tests) for those < 18 months of age

     

     

     

     

    13383 days

    1340Human papillomavirus (HPV) associated laryngeal papillomas or recurrent respiratory papillomatosis in children < 6 years of age *8

     

     

     

     

    1352X

     

     

     

    1353HPV DNA

     

     

     

    1355X

     

    1356Human papillomavirus (HPV) – anogenital papillomas in children < 12 years of age *8

     

     

    1364X

     

    1365HPV DNA

     

     

     

    1367X

     

    1368Human papillomavirus (HPV)

    1371Practitioner Reporting Not Applicable

    1375HPV DNA *3

     

     

     

    1378X

     

    1379Influenza due to novel or pandemic strains

    1386X

    1387X

     

     

    1388Isolation of influenza virus from humans of a novel or pandemic strain

    1400X

    1401X

    1402X

     

     

    1403Influenza-associated pediatric mortality in persons aged < 18 years

     

    1409X

     

     

    1410Influenza virus – associated pediatric mortality in persons aged < 18 years (if known)

    1419X

     

    1420X

     

     

    1421Influenza

    1422Practitioner Reporting Not Applicable

    1426Influenza virus, all test results (positive and negative) *3

     

     

     

    1435X

     

    1436Lead poisoning *4, 16

     

     

    1440X

     

    1441All blood lead test results (positive and negative) *3, 4, 16

     

     

     

    1452X

     

    1453Legionellosis

     

     

    1454X

     

    1455Legionella 1456species

     

     

     

    1457X

     

    1458Leptospirosis

     

     

    1459X

     

    1460Leptospira species

     

     

     

    1462X

     

    1463Listeriosis

     

    1464X

     

     

    1465Listeria monocytogenes

    1467X

     

    1468X

     

     

    1469Lyme disease

     

     

    1471X

     

    1472Borrelia burgdorferi

     

     

     

    1474X

     

    1475Lymphogranuloma Venereum (LGV)

     

     

    1478X

     

    1479Chlamydia trachomatis

     

     

     

    1481X

     

    1482Malaria

     

     

    1483X

     

    1484Plasmodium 1485species

    1486X

     

     

    1487X

     

    1488Measles (Rubeola)

    1490X

    1491X

     

     

    1492Measles virus *16

    1495X

    1496X

    1497X

     

     

    1498Melioidosis

    1499X

    1500X

     

     

    1501Burkholderia pseudomallei

    1503X

    1504X

    1505X

     

     

    1506Meningitis, bacterial or

    1509mycotic

     

     

    1510X

     

    1511Isolation or demonstration of any bacterial or fungal species in cerebrospinal fluid

     

     

     

    1523X

     

    1524Meningococcal disease

    1526X

    1527X

     

     

     

     

    1528Neisseria meningitidis

    1530X

     

    1531X

     

     

    1532Mercury poisoning *4a

     

     

    1535X

     

    1536Laboratory results as specified in the surveillance case definition *4a

     

     

     

     

    1546X

     

    1547Mumps

     

     

    1548X

     

    1549Mumps virus

     

     

     

    1551X

     

    1552Neonatal Abstinence Syndrome *18

     

     

     

    15566 months

    1558Neonatal Abstinence Syndrome

    1561Laboratory Reporting Not Applicable

    1565Neurotoxic shellfish poisoning

     

    1568X

     

     

    1569Laboratory results as specified in the surveillance case definition *4a

     

     

    1579X

     

     

    1580Pertussis

     

    1581X

     

     

    1582Bordetella pertussis

     

     

    1584X

     

     

    1585Pesticide-related illness and injury *4

     

     

    1590X

     

    1591Laboratory results as specified in the surveillance case definition *4

     

     

     

    1601X

     

    1602Plague

    1603X

    1604X

     

     

    1605Yersinia pestis

    1607X

    1608X

    1609X

     

     

    1610Poliomyelitis

    1611X

    1612X

     

     

    1613Poliovirus

    1614X

    1615X

    1616X

     

     

    1617Psittacosis (Ornithosis)

     

     

    1619X

     

    1620Chlamydophila psittaci

    1622X

     

     

    1623X

     

    1624Q Fever

     

     

    1626X

     

    1627Coxiella burnetii

    1629X

     

     

    1630X

     

    1631Rabies, animal or human

     

    1635X

     

     

    1636Rabies virus

     

    1638X

    1639X

     

     

    1640Rabies, possible exposure *19

    1644X

    1645X

     

     

    1646Rabies, possible exposure

    1649Laboratory Reporting 1651Not Applicable

    1653Respiratory syncytial virus

    1656Practitioner Reporting Not Applicable

    1660Respiratory syncytial virus, all test results (positive and negative) *3

     

     

     

    1670X

     

    1671Ricin toxicity

    1673X

    1674X

     

     

    1675Ricinine (from 1677Ricinus communis 1679castor beans)

    1681X

    1682X

    1683X

     

     

    1684Rocky 1685Mountain 1686spotted fever and other Spotted Fever Rickettsioses

     

     

    1693X

     

    1694Rickettsia rickettsii 1696and other Spotted Fever 1700Rickettsia 1701species

    1702X

     

     

    1703X

     

    1704Rubella, including congenital

    1707X

    1708X

     

     

    1709Rubella virus *17

    1712X

    1713X

    1714X

     

     

    1715St. Louis encephalitis (SLE)

     

     

    1719X

     

    1720St. Louis encephalitis virus

    1724X

     

     

    1725X

     

    1726Salmonellosis *4b

     

     

    1728X

     

    1729Salmonella 1730species *4b

    1732X

     

     

    1733X

     

    1734Saxitoxin poisoning including Paralytic shellfish poisoning (PSP)

     

     

    1741X

     

    1742Saxitoxin

     

     

     

    1743X

     

    1744Severe acute respiratory disease syndrome-associated with a Coronavirus infection

    1753X

    1754X

     

     

    1755Coronavirus associated with severe acute respiratory disease

    1762X

    1763X

    1764X

     

     

    1765Shigellosis *4b

     

     

    1767X

     

    1768Shigella 1769species *4b

     

     

     

    1771X

     

    1772Smallpox

    1773X

    1774X

     

     

    1775Variola virus (orthopox virus)

    1779X

    1780X

    1781X

     

     

    1782Staphylococcus aureus 1784isolated from a normally sterile site

    1790Practitioner Reporting Not Applicable

    1794Staphylococcus aureus 1796isolated from a normally sterile site *3

     

     

     

    1803X

     

    1804Staphylococcus aureus 1806with intermediate or full resistance to vancomycin (VISA,VRSA)

     

    1815X

     

     

    1816Staphylococcus aureus 1818with intermediate or full resistance to vancomycin (VISA, VRSA); Laboratory results as specified in the surveillance case definition *4

    1837X

     

    1838X

     

     

    1839Staphylococcus enterotoxin B

     

    1842X

     

     

    1843Staphylococcus enterotoxin B

    1846X

     

    1847X

     

     

    1848Streptococcus pneumoniae, 1850invasive disease in children < 6 years, drug sensitive and resistant

     

     

    1854X

     

    1855Streptococcus pneumoniae, 1857all ages, isolated from a normally sterile site *20

     

     

     

    1866X

     

    1867Syphilis

     

     

    1868X

     

    1869Treponema pallidum

     

     

     

    1871X

     

    1872Syphilis in pregnant women and neonates

     

    1878X

     

     

    1879Treponema pallidum

     

     

    1881X

     

     

    1882Tetanus

     

     

    1883X

     

    1884Clostridium tetani

     

     

     

    1886X

     

    1887Trichinellosis (Trichinosis)

     

     

    1889X

     

    1890Trichinella spiralis

     

     

     

    1892X

     

    1893Tuberculosis (TB) *21

     

     

    1896X

     

    1897Mycobacterium tuberculosis 1899complex *21

    1901X

     

     

    1902X

     

    1903Tularemia

    1904X

    1905X

     

     

    1906Francisella tularensis

    1908X

    1909X

    1910X

     

     

    1911Typhoid fever and paratyphoid fever *4b

     

    1917X

     

     

    1918Salmonella enterica 1920serotype Typhi and 1923Salmonella enterica 1925serotypes Paratyphi A, Paratyphi B, and Paratyphi C *4b

    1934X

     

    1935X

     

     

    1936Typhus fever (epidemic)

    1939X

    1940X

     

     

    1941Rickettsia prowazekii

    1943X

    1944X

    1945X

     

     

    1946Vaccinia disease

    1948X

    1949X

     

     

    1950Vaccinia virus

    1952X

    1953X

    1954X

     

     

    1955Varicella (Chickenpox) *22

     

     

    1958X

     

    1959Varicella virus

     

     

     

    1961X

     

    1962Varicella mortality

     

     

    1964X

     

    1965Varicella virus

     

     

     

    1967X

     

    1968Venezuelan equine encephalitis

    1971X

    1972X

     

     

    1973Venezuelan equine encephalitis virus

    1977X

    1978X

    1979X

     

     

    1980Vibriosis (infections by 1983Vibrio 1984species and closely related organisms, other than Cholera)

     

     

    1992X

     

    1993All non-cholera 1995Vibrio 1996species 1997Photobacterium damselae, 1999(formerly 2000V. damsela2002); 2003Grimontia hollisae 2005(formerly 2006V. hollisae2008)

    2009X

     

     

    2010X

     

    2011Viral hemorrhagic fevers

    2014X

    2015X

     

     

    2016Ebola, 2017Marburg, 2018Lassa, Machupo Lujo, new world Arena, or Congo-Crimean hemorrhagic fever viruses

    2029X

    2030X

    2031X

     

     

    2032West Nile virus (disease due to)

     

     

     

    2038X

     

     

    2039West Nile 2041virus

    2042X

     

     

    2043X

     

    2044Yellow fever

    2046X

    2047X

     

     

    2048Yellow fever virus

    2051X

     

    2052X

     

     

    2053Zika fever *5

    2056X

     

     

     

    2057Zika fever virus *5

    2061X

    2062X

     

     

     

     

    2063*1 – Submission of isolates or specimens for confirmation to the Florida Department of Health, Bureau of Public Health Laboratories:

    2083a. Each laboratory that obtains a human isolate or a specimen from a patient shall send isolates or specimens (such as sera, slides or diagnostic preparations) for confirmation or additional characterization of the organism.

    2117b. Hospitals, practitioners and laboratories submitting specimens for reportable laboratory tests, pursuant to subsection 213164D-3.031(3), 2132F.A.C., are required to supply the laboratories with sufficient information to comply with the provisions of this section.

    2150c. For the address of the closest Florida Department of Health laboratory location, contact: 1(866)352-5227.

    2165d. Laboratories shall submit isolates or specimens for confirmation or additional characterization of the organism for any reportable disease listed in the 2187Table of Reportable Diseases or Conditions to be Reported 2196in this rule as requested by the Department.

    2204e. Laboratories are not prohibited from submitting isolates or specimens from a patient for a disease or condition that is not designated in the 2228Table of Reportable Diseases or Conditions to be Reported 2237in this rule.

    2240f. Submission should occur within two weeks from the time the isolate or specimen is received by the laboratory, unless otherwise noted by the Department.

    2265*2 2266 2267Include MIC (minimum inhibitory concentration), zone sizes for disk diffusion; MICs for E-test or agar dilution and interpretation (susceptible, intermediate, resistant).

    2288*3 – Paper reports are not required. Applies only to laboratories performing electronic laboratory reporting as described in subsection 230764D-3.031(5), 2308F.A.C.

    2309*4 – a. Surveillance Case Definitions for Select Reportable Diseases in Florida, 2016.

    2322b. Reports should include occupational information (e.g. employer name, address, phone number).

    2334*5 – Report on suspicion of infection. Reports should occur without delay on initial suspicion but reports do not need to be made after-hours. Reports on initial suspicion are to allow for disease control measures to be immediately implemented (such as notification of mosquito control) in order to prevent local transmission.

    2385*6 – Notification within six months of diagnosis and within six months of each treatment.

    2400*7 – All CD-4 absolute count and percentage of total lymphocytes, with or without confirmed HIV infection.

    2417*8 – Child abuse should be considered by a practitioner upon collection of a specimen for laboratory testing in any person 12 years of age or younger, excluding neonates. Reporting of a sexually transmissible disease (STD) case to a county health department does not relieve the practitioner of their mandatory reporting responsibilities regarding child abuse pursuant to Section 247539.201, F.S.

    2477*9 – Exceptions are located in Rule 248464D-3.035, 2485F.A.C.

    2486*10 – Practitioners should contact the Department of Health, Bureau of Epidemiology at (850)245-4401 to arrange appropriate autopsy and specimen collection.

    2507*11 – For 2510Haemophilus influenza 2512test results associated with persons older than 4 years of age, only electronic reporting is required, in accordance with subsection 253264D-3.031(5), 2533F.A.C.

    2534*12 – Special reporting requirements for Hepatitis B (acute and chronic), C (acute and chronic), D, E, G: Positive results should be accompanied by any hepatitis testing conducted (positive and negative results); all serum aminotransferase levels, and if applicable, pregnancy test result or if testing is conducted as part of a pregnancy panel. For laboratories performing electronic laboratory reporting as described in subsection 259764D-3.031(5), 2598F.A.C., all test results performed (positive and negative) are to be submitted, including screening test results (positive and negative).

    2617*13 – A 4-fold titer rise in paired sera by various serological tests confirmatory of primary infection; presence of herpes-specific IgM suggestive but not conclusive evidence of primary infection.

    2646*14 – Special requirements for STARHS (Serologic Testing Algorithm for Recent HIV Seroconversion):

    2659a. Laboratories that report a confirmed positive HIV 2667tests in persons ≥13 years old must also report STARHS results.

    2678b. In lieu of producing this test result, each laboratory that reports a confirmed positive HIV test must submit a sample for additional testing using STARHS. The laboratory is permitted to s2710end the remaining blood specimen or an aliquot of at least 0.5 2722ml 2723to the Bureau of Public Health Laboratories, 1217 Pearl Street, Jacksonville, Florida 32202-3926 or 1325 NW 14th Avenue, Miami, Florida 33125.

    2744c. Laboratories electing to send a blood specimen will contact the Incidence and Molecular Coordinator, HIV/AIDS Section, Florida Department of Health, at (850)245-4430 to receive specimen maintenance and shipping instructions.

    2774d. Nationally based laboratories with an existing contract to ship specimens directly to a STARHS laboratory designated by the Centers for Disease Control and Prevention will not be required to send a specimen to the Department.

    2810*15 – 2812Laboratories shall submit a genotype for each confirmed positive HIV specimen on a fasta file containing the nucleotide sequence data, including the protease and reverse transcriptase regions.

    2839*16 – Special reporting requirements for reporting blood lead tests:

    2849a. All blood lead tests are considered evidence of a suspected case and are to be reported electronically. This reporting requirement pertains to: 1) laboratories and, 2) practitioners that conduct on-site blood lead analysis (i.e., practitioners that use portable lead care analyzers or other devices to perform blood lead analysis).

    2899b. Results produced by on-site blood lead analysis devices (i.e., portable lead care analyzers or other portable devices used to perform blood lead analysis) less than 10 µg/dL must be reported within 10 business days. Electronic reporting of results is preferred.

    2940*17 – IgM serum antibody or viral culture test orders for measles (rubeola) or rubella should be reported as suspect immediately, but not IgG orders or results.

    2967*18 – Each hospital licensed under Chapter 395, F.S., shall report each case of neonatal abstinence syndrome occurring in an infant admitted to the hospital.  If a hospital reports a case of neonatal abstinence syndrome to the Agency for Health Care Administration in its inpatient discharge data report, pursuant to Chapter 59E-7, F.A.C., then it need not comply with the reporting requirements of subsection 303164D-3.029(1), 3032F.A.C.

    3033*19 – Exposure to Rabies, as defined in Rule 304264D-3.028, 3043F.A.C., that results in rabies prophylaxis for the person exposed, rabies testing, isolation or quarantine of the animal causing the exposure.

    3064*20 3065– F3067or 3068Streptococcus pneumonia 3070test results associated with persons older than 5 years, only electronic reporting is required, in accordance with subsection 308864D-3.031(5), 3089F.A.C.

    3090*21 – 3092Test results must be submitted by laboratories to the Department of Health, Tuberculosis Control Section, 4052 Bald Cypress Way, Bin A20, Tallahassee, Florida 32399-1717, (850)245-4350.

    3117*22 – Practitioners shall also provide dates of varicella vaccination.

    3127Rulemaking Authority 3129381.0011(2), 3130381.003(2), 3131381.0031(8), 3132384.33, 3133392.53(2), 3134392.66 FS. 3136Law Implemented 3138381.0011(3), 3139(4), 3140381.003(1), 3141381.0031(2), 3142(4), (5), (6), (8), 3146383.06, 3147384.25, 3148385.202, 3149392.53 FS. 3151History–New 11-20-06, Amended 11-24-08, 6-4-14, 10-20-16.

     

Rulemaking Events:

Historical Versions(3)

Select effective date to view different version.